Medicare Enrolled
Dr. Steven Frank, D.O.
Family Medicine · Rehoboth, MA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Frank from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Frank?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Frank
Dr. Steven Frank is a family medicine specialist in Rehoboth, MA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Frank performed 1,524 Medicare services across 1,037 unique beneficiaries.
Between the years covered by Open Payments, Dr. Frank received a total of $16,170 from 51 pharmaceutical and/or device companies across 689 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Frank is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 15% volume in MA
$16,170 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,524
Medicare services
Top 15% in MA for family medicine
1,037
Unique beneficiaries
$69
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~80 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
575 | $89 | $339 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
123 | $59 | $231 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
119 | $134 | $285 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
102 | $8 | $15 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
97 | $10 | $29 |
| Blood glucose level test A test that measures the amount of sugar in your blood. |
92 | $4 | $12 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
86 | $31 | $55 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
71 | $72 | $124 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
46 | $143 | $441 |
| Home health plan of care re-certification A physician reviews the patient's status and contacts the home health agency to re-certify the plan of care without the patient being present. |
35 | $32 | $100 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
26 | $43 | $130 |
| COVID-19 vaccine administration Administration of a single dose of the coronavirus vaccine. |
25 | $42 | $60 |
| COVID-19 vaccine (Moderna bivalent) An intramuscular injection of the SARS-CoV-2 vaccine containing 50 micrograms in a 0.5 mL dose. |
25 | $132 | $185 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
23 | $11 | $50 |
| Assessment of emotional or behavioral problems An evaluation to identify and understand emotional or behavioral issues. This process involves reviewing symptoms and behaviors to determine the nature of the concerns. |
20 | $3 | $20 |
| Pneumococcal conjugate vaccine (PCV20) An intramuscular injection of the 20-valent pneumococcal conjugate vaccine. It is used to protect against diseases caused by Streptococcus pneumoniae bacteria. |
18 | $281 | $432 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
17 | $31 | $80 |
| Quadrivalent influenza vaccine, cell-culture derived A flu shot containing four strains of influenza virus, produced using cell culture technology rather than eggs. This formulation is free from preservatives and antibiotics. |
12 | $33 | $61 |
| Initial preventive physical examination, new Medicare beneficiary A comprehensive preventive health visit for new Medicare beneficiaries during their first 12 months of enrollment. The service is conducted as a face-to-face visit and is limited to preventive care. |
12 | $170 | $373 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$16,170
Total received (2018-2024)
Avg $2,310/year across 7 years
Top 1% in MA for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
51
Companies
689
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,170 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,379
2023
$2,534
2022
$1,948
2021
$2,199
2020
$1,157
2019
$2,713
2018
$3,240
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$398
PFIZER INC.
$275
GlaxoSmithKline, LLC.
$234
Abbott Laboratories
$224
Novo Nordisk Inc
$206
Exact Sciences Corporation
$136
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$131
Vanda Pharmaceuticals Inc.
$125
Lilly USA, LLC
$120
Otsuka America Pharmaceutical, Inc.
$113
E.R. Squibb & Sons, L.L.C.
$84
ABBVIE INC.
$71
Merck Sharp & Dohme LLC
$55
Seqirus USA Inc
$47
Boehringer Ingelheim Pharmaceuticals, Inc.
$40
Astellas Pharma US Inc
$33
Bayer Healthcare Pharmaceuticals Inc.
$32
Xeris Pharmaceuticals, Inc.
$21
SHIELD THERAPEUTICS INC
$20
AIMMUNE THERAPEUTICS, INC.
$14
Top 3 companies account for 38.1% of 2024 payments
All-time payments by company (2018-2024) ›
PFIZER INC.
$2,176
AstraZeneca Pharmaceuticals LP
$2,175
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,368
Janssen Pharmaceuticals, Inc
$1,233
GlaxoSmithKline, LLC.
$1,168
Novo Nordisk Inc
$966
Lilly USA, LLC
$664
Abbott Laboratories
$537
Biohaven Pharmaceuticals, Inc.
$514
Teva Pharmaceuticals USA, Inc.
$502
Allergan Inc.
$446
ABBVIE INC.
$423
Merck Sharp & Dohme Corporation
$378
SANOFI-AVENTIS U.S. LLC
$358
E.R. Squibb & Sons, L.L.C.
$269
IDORSIA PHARMACEUTICALS US INC
$224
ITI, Inc.
$217
Exact Sciences Corporation
$205
Biohaven Pharmaceutical Holding Company Ltd.
$199
Kerecis Limited
$176
Sunovion Pharmaceuticals Inc.
$152
Merck Sharp & Dohme LLC
$141
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$131
Vanda Pharmaceuticals Inc.
$125
BioDelivery Sciences International, Inc.
$123
Shire North American Group Inc
$121
Seqirus USA Inc
$115
Otsuka America Pharmaceutical, Inc.
$113
Bayer HealthCare Pharmaceuticals Inc.
$94
Purdue Pharma L.P.
$92
JAZZ PHARMACEUTICALS INC.
$91
Bayer Healthcare Pharmaceuticals Inc.
$87
Dynavax Technologies Corporation
$63
Daiichi Sankyo Inc.
$58
Axsome Therapeutics, Inc.
$53
SANOFI PASTEUR INC.
$49
AbbVie Inc.
$46
Eisai Inc.
$40
Xeris Pharmaceuticals, Inc.
$35
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$35
Astellas Pharma US Inc
$33
Sanofi Pasteur Inc.
$23
Alexion Pharmaceuticals, Inc.
$22
SHIELD THERAPEUTICS INC
$20
Takeda Pharmaceuticals U.S.A., Inc.
$20
Circassia Pharmaceuticals Inc
$18
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$18
Lundbeck LLC
$16
AIMMUNE THERAPEUTICS, INC.
$14
Bausch Health US, LLC
$14
AbbVie, Inc.
$12
Top 3 companies account for 35.4% of all-time payments
Associated products mentioned in payments ›
ABILIFY MAINTENA · ACCRUFER · AIRSUPRA · AJOVY · ANORO · ANORO ELLIPTA · APLENZIN · AREXVY · AUSTEDO · AirDuo Digihaler · Amitiza · BELBUCA · BELSOMRA · BEVESPI AEROSPHERE · BEXSERO · BREO · BREZTRI · BRINTELLIX · CAPLYTA · CHANTIX · COBENFY · COLOGUARD · Cologuard Collection Kit · Dayvigo · ELIQUIS · EMGALITY · EUCRISA · FANAPT · FARXIGA · FLUCELVAX QUADRIVALENT · FLUZONE QUADRIVALENT · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · Fluad · Fluad Quadrivalent · Flucelvax · GARDASIL · GARDASIL 9 · GVOKE HYPOPEN · GVOKE PFS · Heplisav-B · INJECTAFER · INVOKANA · JANUVIA · JARDIANCE · Kerecis Omega3 SurgiClose · Kerendia · LATUDA · LYRICA · LifeVest · MOUNJARO · NATPARA · NATPARA (PARATHYROID HORMONE) · NURTEC ODT · OFEV · Ozempic · PAXLOVID · PENTACEL · PNEUMOVAX 23 · PREMARIN · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · QULIPTA · QUVIVIQ · QVAR · REXULTI · REYVOW · ROTATEQ · RYBELSUS · Rybelsus · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · SPIRIVA · SPIRIVA RESPIMAT · STEGLATRO · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · SYMPROIC · Saxenda · Strensiq · Sunosi · Synthroid · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRULICITY · TRUMENBA · TUDORZA PRESSAIR · Tresiba · UBRELVY · UTIBRON · Utibron · VAXELIS · VIBERZI · VOWST · VRAYLAR · VYVANSE · Veozah · Victoza · Wegovy · XARELTO · XIFAXAN
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 1% for family medicine in MA.
Geographic Context
Family medicine physicians within 10 mi
642
Per 100K population
111.0
County median income
$84,198
Nearest hospital
STURDY MEMORIAL HOSPITAL
6.4 mi
6.4 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Frank is a clinical cardiology specialist, with above-average Medicare volume (top 15% in MA), with low-engagement industry engagement in the top 1% of MA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Frank experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Frank performed 575 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Frank receive payments from pharmaceutical companies?
Yes. Dr. Frank received a total of $16,170 from 51 companies across 689 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Frank's costs compare to other family medicine physicians in Rehoboth?
Dr. Frank's average Medicare payment per service is $69. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Frank) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Rehoboth
Browse family medicine physicians in Rehoboth ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in MA
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in MA
Which MA family medicine physicians receive the most from drug and device companies.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology